Modeling of Personalized Treatments in Colon Cancer Based on Preclinical Genomic and Drug Sensitivity Data

SIMPLE SUMMARY: This experimental preclinical study developed a strategy to identify signatures for the personalized treatment of colon cancer focusing on target-specific drug combinations. Tumor growth inhibition was analyzed in a preclinical phase II study using 25 patient-derived xenograft models...

Descripción completa

Detalles Bibliográficos
Autores principales: Keil, Marlen, Conrad, Theresia, Becker, Michael, Keilholz, Ulrich, Yaspo, Marie-Laure, Lehrach, Hans, Schütte, Moritz, Haybaeck, Johannes, Hoffmann, Jens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656546/
https://www.ncbi.nlm.nih.gov/pubmed/34885128
http://dx.doi.org/10.3390/cancers13236018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656546/
https://www.ncbi.nlm.nih.gov/pubmed/34885128
http://dx.doi.org/10.3390/cancers13236018

Ejemplares similares